rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-12-23
|
pubmed:abstractText |
Patients with non-small cell lung carcinoma with epidermal growth factor receptor (EGFR) mutations may have a more favorable prognosis and greater response to chemotherapy. The effect of EGFR mutation and gene copy on patients with early-stage non-small cell lung carcinoma receiving adjuvant chemotherapy has not been reported.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1556-1380
|
pubmed:author |
pubmed-author:Aviel-RonenSaritS,
pubmed-author:DingKeyueK,
pubmed-author:GandaraDavidD,
pubmed-author:JohnsonDavid HDH,
pubmed-author:Le MaîtreAurélieA,
pubmed-author:LiuNiN,
pubmed-author:LudkovskiOlgaO,
pubmed-author:RigasJames RJR,
pubmed-author:SakuradaAkiraA,
pubmed-author:SeymourLesleyL,
pubmed-author:ShepherdFrances AFA,
pubmed-author:TsaoMing-SoundMS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-47
|
pubmed:meshHeading |
pubmed-meshheading:21107284-Adenocarcinoma,
pubmed-meshheading:21107284-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21107284-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21107284-Carcinoma, Squamous Cell,
pubmed-meshheading:21107284-Chemotherapy, Adjuvant,
pubmed-meshheading:21107284-Cisplatin,
pubmed-meshheading:21107284-DNA, Neoplasm,
pubmed-meshheading:21107284-Female,
pubmed-meshheading:21107284-Gene Dosage,
pubmed-meshheading:21107284-Humans,
pubmed-meshheading:21107284-Lung Neoplasms,
pubmed-meshheading:21107284-Male,
pubmed-meshheading:21107284-Mutation,
pubmed-meshheading:21107284-Neoplasm Staging,
pubmed-meshheading:21107284-Polymerase Chain Reaction,
pubmed-meshheading:21107284-Prognosis,
pubmed-meshheading:21107284-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21107284-Survival Rate,
pubmed-meshheading:21107284-Vinblastine
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
|
pubmed:affiliation |
Department of Pathology, University Health Network, Princess Margaret Site, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|